Blau Farmaceutica stock closes at B3 after October 30 session

Blau Farmaceutica stock traded at 9.02 Brazilian reais on B3 at 5:03 p.m. Brasília time on Friday, October 30, 2026. The quote reflects the latest available close for the Brazilian listing.

Results date comes into focus

Blau Farmaceutica has scheduled its third-quarter 2026 results videocast for Wednesday, November 11, according to the company's investor-relations page. The event is listed for 9:00 a.m. New York time, 2:00 p.m. London time and 11:00 a.m. Brasília time.

The company's first-half revenue was reported at BRL 922 million, an increase of 10 percent from a year earlier, while a sector preview published on October 19 pointed to potential operational improvement in the third quarter. That outlook remains an expectation ahead of the company's scheduled results presentation.

Hospital medicines remain central

Blau Farmaceutica develops and supplies complex medicines for the institutional pharmaceutical market, with business units covering biotechnology, oncology, specialty products and other medicines. Its portfolio serves therapeutic areas including immunology, hematology, nephrology, infectious diseases and cancer treatment. The company supplies hospitals, private clinics, chemotherapy and hemodialysis centers and public health institutions across Brazil and selected international markets.

Brazilian equities can be followed through current market reports.

More news and analyses on Blau Farmaceutica stock are available in the topic section.